Yun Zhong
Stock Analyst at Wedbush
(1.33)
# 3,489
Out of 4,918 analysts
32
Total ratings
42.86%
Success rate
-10.98%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yun Zhong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WVE Wave Life Sciences | Reiterates: Outperform | $18 | $8.63 | +108.57% | 1 | Jun 23, 2025 | |
| KROS Keros Therapeutics | Reiterates: Neutral | $15 | $14.32 | +4.75% | 2 | May 30, 2025 | |
| CAMP Camp4 Therapeutics | Initiates: Outperform | $8 | $1.65 | +384.85% | 1 | May 27, 2025 | |
| RCKT Rocket Pharmaceuticals | Reiterates: Outperform | $32 | $2.99 | +970.23% | 2 | May 16, 2025 | |
| ASND Ascendis Pharma | Maintains: Outperform | $181 → $212 | $174.48 | +21.50% | 1 | May 2, 2025 | |
| PTGX Protagonist Therapeutics | Reiterates: Outperform | $70 | $53.83 | +30.04% | 2 | Mar 28, 2025 | |
| VYGR Voyager Therapeutics | Reiterates: Outperform | n/a | $2.96 | - | 1 | Mar 12, 2025 | |
| PASG Passage Bio | Assumes: Outperform | $80 | $5.74 | +1,293.73% | 2 | Nov 29, 2024 | |
| MLTX MoonLake Immunotherapeutics | Assumes: Outperform | $92 → $73 | $52.92 | +37.94% | 1 | Nov 5, 2024 | |
| RZLT Rezolute | Initiates: Outperform | $12 | $5.87 | +104.43% | 1 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $28 | $11.20 | +150.00% | 2 | Feb 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.63 | - | 2 | Feb 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $16 | $6.32 | +153.37% | 1 | Jan 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $125 → $160 | $15.91 | +905.66% | 11 | Dec 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $46 | $13.70 | +235.89% | 1 | Jun 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.66 | +502.41% | 1 | May 5, 2021 |
Wave Life Sciences
Jun 23, 2025
Reiterates: Outperform
Price Target: $18
Current: $8.63
Upside: +108.57%
Keros Therapeutics
May 30, 2025
Reiterates: Neutral
Price Target: $15
Current: $14.32
Upside: +4.75%
Camp4 Therapeutics
May 27, 2025
Initiates: Outperform
Price Target: $8
Current: $1.65
Upside: +384.85%
Rocket Pharmaceuticals
May 16, 2025
Reiterates: Outperform
Price Target: $32
Current: $2.99
Upside: +970.23%
Ascendis Pharma
May 2, 2025
Maintains: Outperform
Price Target: $181 → $212
Current: $174.48
Upside: +21.50%
Protagonist Therapeutics
Mar 28, 2025
Reiterates: Outperform
Price Target: $70
Current: $53.83
Upside: +30.04%
Voyager Therapeutics
Mar 12, 2025
Reiterates: Outperform
Price Target: n/a
Current: $2.96
Upside: -
Passage Bio
Nov 29, 2024
Assumes: Outperform
Price Target: $80
Current: $5.74
Upside: +1,293.73%
MoonLake Immunotherapeutics
Nov 5, 2024
Assumes: Outperform
Price Target: $92 → $73
Current: $52.92
Upside: +37.94%
Rezolute
Nov 5, 2024
Initiates: Outperform
Price Target: $12
Current: $5.87
Upside: +104.43%
Feb 9, 2023
Maintains: Buy
Price Target: $35 → $28
Current: $11.20
Upside: +150.00%
Feb 2, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.63
Upside: -
Jan 18, 2023
Maintains: Buy
Price Target: $14 → $16
Current: $6.32
Upside: +153.37%
Dec 22, 2022
Maintains: Buy
Price Target: $125 → $160
Current: $15.91
Upside: +905.66%
Jun 15, 2021
Initiates: Buy
Price Target: $46
Current: $13.70
Upside: +235.89%
May 5, 2021
Initiates: Buy
Price Target: $10
Current: $1.66
Upside: +502.41%